NYLIM
AMGN icon

New York Life Investment Management’s Amgen AMGN Stock Holding History

New York Life Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.3M Buy
74,823
+968
+1% +$345K 0.22% 82
2025
Q4 		$24.2M Buy
73,855
+719
+1% +$228K 0.21% 92
2025
Q3 		$20.6M Sell
73,136
-505
-0.7% -$146K 0.18% 105
2025
Q2 		$20.6M Buy
73,641
+1,357
+2% +$384K 0.19% 105
2025
Q1 		$22.5M Sell
72,284
-406
-0.6% -$120K 0.23% 88
2024
Q4 		$18.9M Buy
72,690
+388
+0.5% +$115K 0.19% 105
2024
Q3 		$23.3M Sell
72,302
-1,792
-2% -$586K 0.23% 90
2024
Q2 		$23.2M Buy
74,094
+566
+0.8% +$166K 0.23% 77
2024
Q1 		$20.9M Sell
73,528
-2,888
-4% -$845K 0.21% 90
2023
Q4 		$22M Sell
76,416
-798
-1% -$217K 0.23% 83
2023
Q3 		$20.8M Sell
77,214
-7,414
-9% -$1.85M 0.22% 83
2023
Q2 		$18.8M Sell
84,628
-38
-0% -$8.82K 0.2% 104
2023
Q1 		$20.5M Buy
84,666
+149
+0.2% +$36.6K 0.23% 92
2022
Q4 		$22.2M Sell
84,517
-308
-0.4% -$82.6K 0.25% 86
2022
Q3 		$19.1M Sell
84,825
-610
-0.7% -$148K 0.23% 90
2022
Q2 		$20.8M Buy
+85,435
New +$20.9M 0.24% 86

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

New York Life Investment Management's AMGN Position: Q1 2026 in Review

New York Life Investment Management increased its Amgen (AMGN) stake by 1.3% in Q1 2026, buying an estimated $345K and bringing the position to 74,823 shares worth $26.3M. The position accounts for 0.22% of the portfolio, ranked #82.

New York Life Investment Management first reported a position in AMGN in Q2 2022 and has held it in 16 quarters since. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • New York Life Investment Management held 74,823 shares of Amgen worth $26.3M as of Q1 2026.
  • New York Life Investment Management bought 968 Amgen shares in Q1 2026, an estimated $345K.
  • Amgen made up 0.22% of New York Life Investment Management's portfolio in Q1 2026, its #82 holding.
  • New York Life Investment Management first reported a position in Amgen in Q2 2022 and has held it in 16 quarters since.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.